New Rochelle, NY, December 2, 2015--A study that simulated the effects of reduced barometic pressure (hypobaria) experienced by patients with traumatic brain injury (TBI) evacuated by air showed that prolonged hypobaria significantly worsened long-term cognitive and neurological outcomes. Maintaining normal oxygen levels did not affect the poorer outcomes after hypobaric exposure, and multiple exposures or use of 100% oxygen further worsened the effects in the rats studied, as described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free to download on the Journal of Neurotrauma website until January 2, 2016.
In "Simulated Aeromedical Evacuation Exacerbates Experimental Brain Injury", Alan Faden, MD led a team of researchers from the Center for Shock, Trauma and Anesthesiology Research (STAR), University of Maryland School of Medicine, Baltimore, in designing a study that simulated the prolonged hypobaria that a soldier with TBI would experience if evacuated by air from the battlefield. The researchers examined the effects on learning, memory, movement, and depressive-like behaviors in rats with induced TBI exposed to 6 hours of hypobaria 24 hours after injury. Some rats were exposed to a second 10-hour hypobaric period 72 hours after injury.
Based on the results of this study, the authors suggest several approaches to limit the negative effects of hypobaric exposure following TBI, including delaying air transport, increasing cabin pressurization to reduce barometric effects, having specialized enclosures to individualize pressurization, or changing supplemental oxygenation protocols.
In the Editorial "Hidden Perils of the 'Wild Blue Yonder' after Traumatic Brain Injury", Patrick M. Kochanek, MD, MCCM and Hülya Bayir, MD, University of Pittsburgh, PA, describe the study as "a valuable and timely exploratory report that takes an early step in addressing a largely unrecognized gap in the pre-clinical and clinical literatures--a gap that is highly relevant to combat casualty care, but also to some cases of civilian trauma." The study authors "appear to have identified a new secondary injury pathway after TBI to add to the list of hypoxemia, hypotension, hyponatremia, hyperthermia, hypertension, hypervolemia, namely, hypobaria that needs to be characterized and prevented to maximize outcomes after TBI--even if patients need to travel into the wild blue yonder."
John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, notes that, "the Journal is exceptionally pleased to report this well done and provocative study that probes important questions relevant to the current standard of combat casualty care during aeromedical evacuation. The reported studies conducted in traumatically brain injured rodents illustrate the damaging consequences of sustained hypobaric exposure, while demonstrating the concomitant adverse consequences associated with the use of 100% oxygen. While additional studies are needed to further refine the overall interpretation of this study, the published work raises the important implication that hypobaria should be considered a potential secondary insult in traumatically brain injured patients."
About the Journal
Journal of Neurotrauma is an authoritative peer-reviewed journal published 24 times per year in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the official journal of the National Neurotrauma Society and the International Neurotrauma Society. Complete tables of content and a sample issue may be viewed on the Journal of Neurotrauma website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Therapeutic Hypothermia and Temperature Management, Brain Connectivity, and Tissue Engineering. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.